Cryo-EM

#AAV #Cryo-EM #cryo-microscopy #Drug discovery #Gene therapy

Quantitative analysis of full and empty particles in adeno-associated virus vectors for gene therapy

In this event, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, presents his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy. In recent years, AAV vectors have been launched and are considered one of the main platforms for gene therapy, with more than 250 clinical… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#Webinars

Protein
#Biopharma #Cryo-EM #Drug discovery #Molecular Biology #Protein degradation

How targeted protein degradation will live up to the hype 

Dr Benedict Cross, CTO, PhoreMost, explores the drug discovery potential that targeted protein degradation (TPD) offers.   The ubiquitin proteasome pathway (UPP) has been a subject of interest for therapeutic intervention since the first proteasome inhibitors to treat multiple myeloma were developed and approved in 2015. The… Read More

#Exclusive Content

Jigsaw puzzle of the brain
#Cryo-EM #Dementia #Medical Research Council #Motor neurone disease #Neurodegenerative disorders #Neuroscience

Researchers identify potential drug target for early-onset dementia

Scientists have identified abnormal aggregates of a protein called TAF15 in the brains of individuals with early-onset dementia, known as frontotemporal dementia, where the cause was not previously known. The research led by scientists from the Medical Research Council (MRC) Laboratory of Molecular Biology, in Cambridge,… Read More

#Editor's Choice #News

#AI / data analytics / healthtech / informatics #Cryo-EM #Curreio #Iktos #Partnership

Drug discovery agreement will combine AI and cryo-EM analysis

As part of a new collaboration, Iktos’ generative design technology and Curreio’s cryo-electron microscopy (cryo-EM) platform will be combined to design novel preclinical drug candidates for an undisclosed target. Iktos’ Makya generative AI technology aims to bring new insights and directions into the molecular discovery process… Read More

#News

#Biopharmaceuticals #Collaboration #Contract Research Organisations (CROs) #Cryo-EM #Drug research #Immunology #Oncology

What’s next for this integrated drug discovery collaboration? 

Galapagos and NovAliX have entered a strategic collaboration in which Galapagos’ research and discovery capabilities and exclusively related employees based in Romainville, France, will be transferred to NovAliX, a drug discovery-focused Contract Research Organisation. The agreement follows Galapagos’ renewed focus on its key therapeutic areas of oncology and… Read More

#News

X-ray showing colon cancer
#Bowel cancer #Cancer research #Cryo-EM #cryo-microscopy #The Institute of Cancer Research

Bowel cancer protein study could lead to less toxic cancer drugs

Scientists have revealed the inner workings of a key protein involved in a wide range of cellular processes – potentially paving the way for better and less toxic cancer drugs.  Using Nobel Prize-winning microscopy techniques, the researchers revealed how the tankyrase protein switches itself on and off… Read More

#Cancer Research #News

Cryo-EM
#Cancer #Cancer research #Cereblon #Cryo-EM #Oncology #Scripps Research

Scientists uncover secret to success in new class of cancer drugs

Scientists have uncovered a critical feature that a promising new class of cancer drugs, known as CELMoDs, needs to be effective.  CELMoDs are designed to attack cancer by binding to a regulatory protein called cereblon, which then triggers the degradation of key cancer-driving proteins.   In… Read More

#Cancer Research #News

#Automation / robotics #Biopharmaceuticals #Cryo-EM #Sample preparation #Webinar

Cryo-EM for understanding potential drug targets

Learn more about the importance of high throughput Cryo-EM on 1 November at 9am PDT, 12pm EDT, 4pm GMT or 5pm CET in this free webinar, hosted by DDW and supported by SPT Labtech. Register for free here. Cryo-EM has been adopted into drug discovery workflows by the pharmaceutical… Read More

#News

#Automation / robotics #Biopharmaceuticals #Cryo-EM #Sample preparation

Cryo-EM and drug discovery workflows: Exclusive webinar

Don’t miss out on this free webinar on 1 November at 9am PDT, 12pm EDT, 4pm GMT, 5pm CET. It is called Utilising novel sample preparation techniques to enhance Cryo-EM structural analysis and is hosted by DDW and supported by SPT Labtech. Confirm your attendance by registering free now. Read More

#News

#Automation / robotics #Biopharmaceuticals #Cryo-EM #Sample preparation

Novel sample preparation techniques enhance Cryo-EM structural analysis

Join DDW on 1 November at 9am PDT, 12pm EDT, 4pm GMT or 5pm CET for this exclusive webinar – Utilising novel sample preparation techniques to enhance Cryo-EM structural analysis. Register free here. Cryo-EM has been adopted into drug discovery workflows by the pharmaceutical and biotechnology industries having proved… Read More

#News